Fulcrum Therapeutics (FULC)
(Delayed Data from NSDQ)
$9.74 USD
+0.57 (6.22%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $9.42 -0.32 (-3.29%) 6:28 PM ET
1-Strong Buy of 5 1
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.41 |
EPS Last Quarter | 0.87 |
Last EPS Surprise | 1,550.00% |
ABR | 1.44 |
Earnings ESP
|
3.83% |
---|---|
Current Year | -0.48 |
Next Year | -1.51 |
EPS (TTM) | -0.35 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 80.00M | 32.88M |
# of Estimates | NA | NA | 4 | 1 |
High Estimate | NA | NA | 80.00M | 32.88M |
Low Estimate | NA | NA | 80.00M | 32.88M |
Year ago Sales | 0.76M | 0.87M | 2.81M | 80.00M |
Year over Year Growth Est. | NA | NA | 2,752.05% | -58.90% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.41 | -0.43 | -0.48 | -1.51 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | -0.38 | -0.39 | -0.45 | -1.14 |
High Estimate | -0.37 | -0.39 | -0.33 | -0.15 |
Low Estimate | -0.48 | -0.50 | -0.76 | -2.20 |
Year ago EPS | -0.39 | -0.40 | -1.59 | -0.48 |
Year over Year Growth Est. | -5.13% | -7.50% | 69.81% | -215.28% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 3 | 3 | 5 | 5 |
Up Last 60 Days | 3 | 3 | 5 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.41 | -0.43 | -0.48 | -1.51 |
7 Days Ago | -0.41 | -0.43 | -0.48 | -1.51 |
30 Days Ago | -0.45 | -0.46 | -1.24 | -1.71 |
60 Days Ago | -0.45 | -0.46 | -1.24 | -1.71 |
90 Days Ago | -0.45 | -0.46 | -1.24 | -1.71 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.40 | -0.42 | -0.42 | -1.37 |
Zacks Consensus Estimate | -0.41 | -0.43 | -0.48 | -1.51 |
Earnings ESP | 3.83% | 3.23% | 11.89% | 9.14% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.87 | -0.43 | -0.40 | -0.39 | NA |
Estimate | -0.06 | -0.44 | -0.44 | -0.44 | NA |
Difference | 0.93 | 0.01 | 0.04 | 0.05 | 0.26 |
Surprise | 1,550.00% | 2.27% | 9.09% | 11.36% | 393.18% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more